HIGHLIGHTS
- who: Andrea Panunzi from the Diabetic Foot Dpt, IRCCS MultiMedica, Milan, Italy have published the article: Results of a prospective observational study of autologous peripheral blood mononuclear cell therapy for no-option critical limb-threatening ischemia and severe diabetic foot ulcers, in the Journal: (JOURNAL)
- what: The authors report the results of a prospective non-controlled observational study on no-option CLTI subjects with diabetes and ischemic foot ulcers that received intramuscular injections of PB-MNCs. Lastly in this study classic cellular markers of the angiogenic response to therapy were assessed. The results provide a . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.